Logo

Editor's Pick

Diagnostics for the Real World Prepares to Launch Retooled Rapid Point-of-Care Testing Platform
Premium

The company, also known as DRW, shared early data on its forthcoming multiplex qPCR-based platform and infectious disease panels at the ESCMID global congress in Vienna.

GeneDx to Offer Genome Interpretation as a Standalone Service Following Fabric Genomics Acquisition
Premium

GeneDx, which has been running a centralized lab, hopes to provide the new service to hospitals in the US and abroad that are already sequencing genomes in-house.

Caszyme, NSage, Vilnius University Partner to Develop CRISPR-Based Diagnostics Platform
Premium

The partners have formed a consortium called Universal CRISPR-based Detection Platform for Versatile and Rapid Diagnostics (UNCOVER).

At ESCMID, Expert Extols New RNA Biomarker, EliTech Assay for Managing CMV Infection Post-Transplant
Premium

The RNA biomarker for monitoring cytomegalovirus infection and therapy efficacy in immunocompromised patients can be quantified with a PCR kit from Bruker's EliTechGroup.

At ESCMID, Data Presented on IL-6 as Early Sepsis Biomarker for Children, Pregnant Women
Premium

IL-6 outperformed traditional sepsis biomarkers like C-reactive protein and procalcitonin in the cohorts.

Apr 11, 2025

Nuclein Advances Point-of-Care Test Menu for 15-Minute PCR System
Premium

Apr 10, 2025

Mirvie Poised to Launch Preeclampsia Test After Publication of Study in 9,000 Pregnancies
Premium

Apr 9, 2025

As Digital PCR Expands Into Oncology, More Clinical Diagnostic Applications on Horizon
Premium

Apr 1, 2025

Future of LDT Oversight Unclear Following Court's Rejection of FDA Rule
Premium

Mar 28, 2025

Federal Funding Disruptions Could Impact Pipeline of Academic Life Science, Diagnostics Spinouts
Premium

Mar 20, 2025

Scout Health Pursuing Point-of-Care, Home MDx Testing Using Novel Multiplexing Chemistry
Premium

Mar 19, 2025

Debate Over Multi-Cancer Screening Tests Shifts Pending Grail Randomized Trial Results
Premium

Mar 17, 2025

Pharma, Dx Leaders Urge MRD Community to Focus on Clinical Utility as Use in Trials Grows
Premium

Mar 14, 2025

European Health Data Space Regulation Stands to Benefit Researchers, Dx Companies
Premium

Mar 4, 2025

Despite Promising Technology, Did Operational Cost Structure Take Down T2 Biosystems?
Premium

Feb 28, 2025

BillionToOne Study Lays Out Evidence for NIPT Fetal RhD Detection Accuracy
Premium

Feb 25, 2025

NYU Team Develops Rapid Digital PCR Workflow to Enable Molecularly Guided Brain Tumor Surgery
Premium

Feb 25, 2025

Pfizer to Shut Down Lucira Health Business by End of Q1
Premium

Feb 25, 2025

Lynx Dx Adds Home-Based Sample Collection in Bid to Expand Reach of its Prostate Cancer MDx
Premium

Feb 13, 2025

Real-World Data Analysis Confirms Pan-Cancer Predictiveness of Foundation Medicine TMB Caller
Premium

Feb 12, 2025

Atila BioSystems Sample Prep Tech Broadening HPV Testing in Low-Resource Countries
Premium

Feb 7, 2025

Oxford Team Debuts Multi-Modal MCED Approach Built on Exact Sciences Methylation Sequencing Tech
Premium

Feb 7, 2025

Brown University Health Pneumonia MDx Development Offers Hint of Digital PCR's Potential as IVD Tool
Premium

Jan 28, 2025

Ireland's OncoAssure Eyes US Market With 'Master Driver' Prostate Cancer Prognostic Test
Premium

Jan 27, 2025

Natera MRD Study Results Demonstrate Potential to Resurrect Failed Adjuvant Drugs
Premium